University of Oxford
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From University of Oxford
Companies in talks with EU authorities for the supply of at least 200 million initial doses of their mRNA vaccine. Plus, other new partnerships around the world and an India pause for AstraZeneca's contender in line with global decision.
New York biotech is partnering with researchers at Columbia, Kansas State and Southern Research to address the pandemic.
Pharma pays $100m up front and makes $20m equity investment for rights to three preclinical cancer programs. Plus more than 20 deal summaries, including COVID-19-related transactions.
The Bayh-Dole act of 1980 facilitated deal-making between private-sector firms and research institutions, largely seeding the US biotech industry. Plus, an overview of the latest tech transfer deals.
- Academic and Research Institutions
- Other Names / Subsidiaries
- Oxford University Innovation